North Star Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

North Star Investment Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.63K	Buy	250 +24	+11%	+$421	﹤0.01%	1209
2025 Q4	$3.52K	Buy	+226	New	+$3.23K	﹤0.01%	1182
2021 Q4	–	Sell	-256	Closed	-$4K	–	1212
2021 Q3	$4K	Hold	256	–	–	﹤0.01%	997
2021 Q2	$4K	Hold	256	–	–	﹤0.01%	969
2021 Q1	$5K	Hold	256	–	–	﹤0.01%	903
2020 Q4	$5K	Sell	256 -297	-54%	-$5.21K	﹤0.01%	874
2020 Q3	$10K	Hold	553	–	–	﹤0.01%	753
2020 Q2	$10K	Hold	553	–	–	﹤0.01%	727
2020 Q1	$8K	Hold	553	–	–	﹤0.01%	758
2019 Q4	$11K	Sell	553 -201	-27%	-$3.85K	﹤0.01%	805
2019 Q3	$13K	Buy	+754	New	+$13K	﹤0.01%	778
2019 Q2	–	Sell	-824	Closed	-$17K	–	867
2019 Q1	$17K	Buy	+824	New	+$16.6K	﹤0.01%	749

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

North Star Investment Management's TAK Position: Q1 2026 in Review

North Star Investment Management increased its Takeda Pharmaceutical (TAK) stake by 11% in Q1 2026, buying an estimated $421 and bringing the position to 250 shares worth $4.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1209.

North Star Investment Management first reported a position in TAK in Q1 2019 and has held it in 12 quarters since. The position peaked at $17K in Q1 2019. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

North Star Investment Management held 250 shares of Takeda Pharmaceutical worth $4.63K as of Q1 2026.
North Star Investment Management bought 24 Takeda Pharmaceutical shares in Q1 2026, an estimated $421.
Takeda Pharmaceutical made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #1209 holding.
North Star Investment Management first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 12 quarters since.
North Star Investment Management's Takeda Pharmaceutical position peaked at $17K in Q1 2019.
358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.